Thomas Rosch Net Worth & Insider Trades

Thomas Rosch Transcept Pharmaceuticals Inc

As of September 23, 2011

What is Thomas Rosch's Net Worth?

The current estimated net worth of Transcept Pharmaceuticals Inc's Thomas Rosch is estimated to be about $14.37M . Thomas Rosch owns about 1,983,884 units of Transcept Pharmaceuticals Inc common stock. Recently at Transcept Pharmaceuticals Inc, Thomas Rosch has sold an estimated value of $0 worth.

What is Thomas Rosch's Past Insider Trading?

Thomas Rosch's largest purchase order was 217,228 units , worth over $1.57M on September 23, 2011. In total, Thomas Rosch has made about 1 transaction recently at Transcept Pharmaceuticals Inc. Thomas Rosch usually trades in September, with the busiest year in 2011.

InterWest Partners IX LP, ARNOLD ORONSKY, PHILIP GIANOS, Gilbert Kliman, HARVEY CASH, Thomas Rosch, Stephen Holmes, KHALED NASR, BRUCE CLEVELAND, Douglas Pepper

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas Rosch's' Mailing Address?

  • Mailing address is C/o Interwest Partners 2710 Sand Hill Road, 2nd Floor Menlo Park CA 94025 CA

What are Transcept Pharmaceuticals Inc's Past Insider Trades?

Transcept Pharmaceuticals Inc's most recent insider trade came on December 17, 2013 by Roumell Asset Management Llc who sold 1,470 units worth $5.2K . In the last 4 years, insiders at Transcept Pharmaceuticals Inc have sold an estimated value of $6.52M and bought an estimated value of $9.99M worth of shares. Insider trading is most common in February, with the busiest year in 2011. The most active traders at the company are Roumell Asset Management Llc,  Glenn Oclassen, President and CEO,  and Marilyn Wortzman, VP .

Transcept Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1